Professional Documents
Culture Documents
ADAPTE method.
Luis Gálvez4, José M García-Herrera5 MD, José M Morales-Asencio6 BSN, MSc, PhD.
PT
1. Clinical Psychologist. Mental Health Unit, Regional University Hospital, Málaga, Spain.
RI
3. Psychiatrist. Mental Health Unit, Regional University Hospital, Málaga, Spain.
SC
4. Care Physician. Health District Málaga- Guadalhorce, Málaga, Spain.
U
6. Professor. Faculty of Health Sciences. University of Málaga, Málaga, Spain.
* Corresponding author:
TE
María M Hurtado
+34 951952833
E-mail: marienahurtado@gmail.com
RR
CO
N
U
© The Author(s) 2020. Published by Oxford University Press in association with the
International Society for Quality in Health Care. All rights reserved. For permissions, please e-
mail: journals.permissions@oup.com
1
Abstract
Generalised anxiety disorder (GAD) is the most frequent anxiety disorder encountered in
limited shared care with mental health services. Clinical guidelines may improve this
PT
scenario, but their development and implementation remains as a major challenge.
Adaptation methods may address these issues. This study aimed to develop a clinical
RI
guideline for improvement of GAD care in a primary care and mental health service in Spain,
SC
using adaptation methods and users’ involvement. The final version included
U
methodological effort.
AN
Keywords: Practice guidelines, Guidelines adherence, Generalised anxiety disorder,
2
Introduction
(1). Generalised anxiety disorder (GAD) is the most common in the group of anxiety
PT
disorders, probably because the DSM criteria for GAD describe anxiety more generally (2).
This condition represents more than 50 % of all anxiety disorders in primary care, with a 12-
RI
month prevalence among adults of 2.9% (3). In health systems that use step care, such as in
SC
Spanish, primary care serves as gateway to the specialised level. It also provide health care
U
In turn, GAD is associated with physical conditions such as cardiovascular disease (4). In
AN
addition, it causes a significant burden of disability, personal suffering and economic burden
(5).
M
In those countries with a strong primary health care (PHC) system, this is the first point of
D
access to the health system for GAD patients; further, most end up receiving their mental
TE
health services at this level. The detection of GAD at during its early phases is a key factor in
providing effective treatment. Nevertheless, in many cases, there is a significant delay in the
EC
person seeking medical help (6); further, there is a low detection rate (7), Even if detected,
One of the ways to deal with this scenario involves the improvement of decision-making
through the implementation of clinical guidelines (CGs). The Institute of Medicine defines
CO
CGs as “statements that include recommendations intended to optimize patient care. They
are informed by a systematic review of evidence and an assessment of the benefits and
N
harms of alternative care options” (9). During the last 20 years, CGs -elaborated rigorously-
U
have become extremely useful instruments for this purpose in health care. Thus, CGs
derived (a) using rigorous and explicit methods; (b) incorporating the best evidence; (c)
groups (thus incorporating patients’ values and preferences) have the potential to
3
significantly improve the quality of care, by reducing the variability of clinical practice and
maximising the impact of CGs. The presence of barriers (e.g. lack of knowledge or familiarity
PT
with CGs) may jeopardise this process, compromising the clarity and/or strength of the
recommendations or those derived from the context of practice (11). Knowledge translation
RI
into practice has focused on overcoming barriers for implementation, although less research
SC
has been conducted to examine long-term adherence to recommendations (12). Many
theories and models have been proposed to address this issue. In this regard, the
U
Consolidated Framework for Implementation Research (CFIR) proposes a meta-theoretical
AN
repository of standardised implementation-related constructs, to be applied for the
The massive development of CGs during the last 20 years has promoted progress on
methods for its design, adaptation and evaluation. The abundance of CGs has yielded
EC
contextualising them in an environment different from the one originally conceived (16).
RR
Producing CGs involves a substantial effort and use of resources, but adaptation methods
permit that this initial endeavour may be applied to different environments, without generating
CO
redundant CGs and optimising efforts (17,18). Moreover, user involvement is a key
component of CGs development and implementation (19). It may empower patients to make
N
more informed health care choices and, overall, support a better decision-making process
U
(20). People who receive mental health care may express satisfaction with services;
however, this is not a guarantee that the best care is being delivered. There still remain
issues for patients in acknowledging they have a mental health problem and seeking help.
They also may fail to build adequate relationships with their health care providers (such as
4
can be developed through participation in their care decisions) or work towards continuity of
care (21). Thus, the combination of adaptation methods with users’ involvement can
In the context of a health care area in Malaga (Spain), with a lengthy tradition (for more than
PT
two decades) involvement in collaborative mental health services, the mental health service,
together with the District of PHC, decided to develop a CG for the improving care for GAD
RI
adult patients being treated at PHC level (through CG-adaptation methods, and incorporating
SC
service users’ testimonies). The aim was to optimise treatment efforts and ensure
methodological accuracy.
U
The aim of this manuscript is to illustrate the process of developing a clinical guideline for
AN
improvement of GAD care in a primary care and mental health service in Spain by using
The CG was developed following guidelines from the ADAPTE group (17,18,22,23), using a
process (e.g. assessment of existing GCs with the AGREE instrument, external review).
Qualitative methods involved focus groups with users to obtain their perspective on domains
RR
included in the CG. This phase was guided according Taylor & Bodgan’s approach to
The professionals who participated were family physicians from PHC, psychiatrists and
psychologists from the primary health care district of Málaga and the unit of mental health
N
from Málaga regional university hospital, which services a reference population of 165,311
U
individuals. The phases of the process are described in Table 1, and took place from 2013 to
2015. The conclusions obtained during the qualitative phase with users have been integrated
into the recommendations of the CG. The criteria to select these service users were to have
5
clinical psychologists and, at least, two appointments for mental health services, in addition
to consultations in PHC, to ensure that they had sufficient experience with different health
care providers.
The objective of this task was to identify which aspects of anxiety disorders generated
PT
uncertainty about their management in our country, especially in PCPs, since most of these
patients are treated at this level. By such means, the GDG could determine which questions
RI
the CG should addresss as a priority.
SC
To identify areas of uncertainty in the management of GAD, we used a framework derived in
a previous work: Clinical Practice Guideline for the treatment of depression in primary care
U
(26,27). Areas contained therein were evaluated by family physicians and psychiatrics for
AN
accetability, appropriateness, and relevance to clinical practice. A modified Delphi process
was used for analysis (26,27). This process was completed with some specific areas for
M
mental health staff, taking into account those suggested by the different CGs evaluated.
D
2. Literature search
TE
Guideline searches were carried out in different data bases, including: National Guidelines
Clearinghouse, CMA InfoBASE, NICE, SIGN, GIN, Institute for Clinical Improvement, NHS
EC
National Library of Guidelines, TRIP Database and Guiasalud. Additional searches were
developed to identify original studies and systematic reviews considering (a) clinical
RR
scenarios not covered by the available CGs and (b) detailed scenarios specifically related to
the Spanish context. These were performed in PubMed, EMBASE, CINHAL, Cochrane
CO
PLUS, Índice Médico Español, and PsycINFO. These scenarios were: epidemiology of GAD
in Spain, frequency of GAD in the Spanish primary health care system, use of quetiapine for
N
GAD and, finally, use of herbal medicines for GAD. A detailed description of the search
U
In total, seven CGs were selected to be evaluated using the AGREE II tool (28). This
selection was made by the GDG; two criteria were taken into account. The first of these was
6
that the GC should address the issue of GAD or, alternatively, it should treat anxiety
disorders in general, limiting some of its recommendations to GAD-related issues. The other
criterion was that they were not outdated at the time of starting the AGREE II tool evaluation.
of CG. It consists of 32 items, grouped into six areas, which should be assessed by 4
PT
independent evaluators. In the present study, CGs were independently evaluated by 4
practitioner: two psychiatrists, a clinical psychologist and a primary care physician (PCP) with
RI
special interest in mental health. Subsequently, the average score in each area was
SC
calculated (Table 2).
The CG of the NICE (29) was the one that obtained the highest rating in each section of the
U
instrument AGREE. Consequently, the NICE guideline was designated as the principal
AN
referenc (using the rest as complementary sources on those aspects where NICE´s would
4. Elaboration of recommendations.
The CG was fully adapted to the model of recommendations established by NICE’s manual
EC
of CGs, so that the main recommendations could be easily identified. Equally, the grading
method used by NICE was the same used for the recommendations. This approach is
RR
adapted from the GRADE system (31); however, there are some differences in (a) appraisal
of the studies´ cost-effectiveness and (b) methods used for the reporting the
CO
recommendations. The combination of the GRADE method used by the original guideline
from NICE and the AGREE instrument to evaluate the quality of the guidelines both provided
N
Once ADAPTE methods were applied, the grade of adaptation could imply three different
situations. The first was adoption of the recommendation without any modification, as far as
it was clear and applicable to the Spanish clinical practice contexts in PHC. The second
7
concerns: (a) the Spanish clinical practice context where the recommendation was going to
be put into practice was substantially different or (b) there was no recommendation in the
Finally, rejection is also possible, due to difficulties applying and/or adapting it to the Spanish
PT
clinical context. This process was developed reviewing each one of the scenarios, in two
phases. During the first phase, when the GDG proposed the draft recommendations, there
RI
was already a first adaptation taking into account the peculiarities of the Andalusian health
SC
system (for example, the resources for the care to intellectual disability or substance use are
not integrated into the health system). Subsequently, during the external review, some
U
reviewers made additional suggestions. These suggestions were valued by the GDG and, in
AN
some cases, it was decided to adapt or eliminate the recommendation. Table 3 shows the
Moreover, “ex novo” searches were generated regarding data of GAD frequency in order to
TE
quetiapine in GAD, and use of herbal remedies in anxiety disorders. These searches were
EC
conducted in order to expand or update these topics from the NICE CG. None of them
Service users were invited to participate in a qualitative study based on focus groups (two
CO
groups of users) through semi-structured interviews addressing the following topics: GAD
impact on daily life and relationships; assessment of the professionals involved (primary care
N
and mental health) and the care process; types of approaches offered in the public health
U
care system (both pharmacological and psychological), perceived usefulness, and personal
resources for coping with anxiety. This information was used to identify possible areas of
8
influence the professionals’ predisposition to comply with recommendations, so that every
user experience (easily recognisable and very familiar for the professionals) had an
evidence-based recommendation.
users’ accounts were literally transcribed and subjected to an initial detailed reading and
PT
detection of emerging issues. Following that, they were coded and grouped into categories
and relevant topics. These codes and categories were triangulated among members of the
RI
GDG to obtain an agreed list, where discrepancies were solved by discussion. Later, the list
SC
of categories was matched against the recommendations. This matching was carried out by
the members of the GDG who conducted the qualitative analysis. As a final point, these
U
matchings were distributed to other members of the GDG to contrast and contextualise these
6. External review
AN
M
The CG was sent to a panel of external reviewers, to be subjected to review. The panel was
D
comprised of nine psychiatrists, ten psychologists, eight family physicians, eight nurses
TE
specialized on mental health or primary care, and one pharmacist. All were active
practitioners treating people with GAD in their daily practice, and with knowledge and interest
EC
in the development of CG. They were asked to evaluate understanding, relevance, feasibility,
and potential barriers to acceptance of the recommendations by a 5-point Likert scale for
RR
7. Implementation toolkit
CO
At the same time, a process for implementing the CG at the PHC of Malaga was designed
prior to the CG dissemination, based on a specific plan with multifaceted interventions. This
N
advisor was included; identification of specific local external barriers in each centre, with
motivation for change) and to the context (colleagues influence, patients, representatives,
organization, time, etc.); appointment of local leaders at each health centre; proactive
9
training with real cases from usual practice that could be resolved following the
recommendations of the CG; use of supporting materials (quick consult material, reminders,
etc.); local dissemination in all the centres; inclusion in the annual commissioning framework
from institutions and scientific societies; consultancy during the process with support and
PT
advice to professionals; detection of areas of improvement in specific local aspects which
could act as barriers, as well as the definition and baseline analysis of indicators for later
RI
audit and feedback to professionals and managers (32).
SC
Internal barriers to implementation were evaluated using the “Guide Line Implementability
Appraisal Tool” in its version 2.0 (33). For this purpose, the CG was appraised independently
U
by two external practitioners (a family physician with special interest in mental health and a
psychiatrist).
AN
M
Results
D
The process resulted in three versions of the Guide: a full CG, a short version, and a brief
TE
version. As a result of the definition of clinical scenarios, the 13 identified uncertainty areas
included scenarios relating to the definition and epidemiological aspects of GAD, assessment
EC
Through the adaptation process, a total of 49 recommendations were adapted (in content or
RR
in wording), 47 of which derived from the NICE CG 2011 on GAD. The remaining two came
from the common mental disorder NICE CG 2011. These two recommendations dealt with
CO
identification of the GAD in primary care. The GDG decided to include them due to the
degree of evidence that supported them and, as well, similarities between the Spanish and
N
English primary care services. All the recommendations were adapted accordingly to the
U
Table 4. The whole themes and categories identified during the qualitative analysis were
10
External review yielded the highest values in relevance (mean 4.7; SD 0.6; range 1 to 5),
followed by understanding (mean 4.6, SD 0.9; range 1 to 5), and patients’ acceptance (mean
4.3; SD 0.7; range 1 to 5). The lowest values were obtained in feasibility (mean 3.9, SD 0.8;
The analysis of barriers and facilitators showed issues focused on competence, continuity of
PT
patient care, and availability of time, in the case of the barriers. The main facilitators reported
by reviewers were related to its methodological quality and the institutional commitment with
RI
the CG (Table 5).
SC
The analysis of internal barriers intrinsic to the CG yielded a high consensus on its
U
novelty. Nevertheless, eight recommendations needed more specifications about practice
AN
characteristics (such as location and availability of support services), and four
Two indicators were defined for monitoring the implementation process, intended to evaluate
TE
changes in the GAD detection and diagnose, as well as treatment decisions, follow-up and
referral to specialised care. Additionally, a set of self-help brochures and guidance was
EC
http://www.juntadeandalucia.es/servicioandaluzdesalud/principal/documentosacc.asp?pagin
RR
a=gr_smental_23_12_gauto_1). The testimonies from the focus groups were linked with 10
recommendations of the CG; these which addressed issues on information about the
CO
Discussion
The aim of this initiative was to develop a CG for managing GAD in PHC, using adaptation
methods. The result is a set of resources that can contribute to improve the quality and
11
effectiveness of the care provided to these patients with a reasonable methodological effort,
Along all the process, 45 people (including authors and reviewers) took part. The effort made
with GAD in PHC, by the use of adaptation methods, to overcome some of the usual
PT
shortcomings in the systematic application of evidence into clinical practice (34,35). It is
remarkably how some CGs evaluated by the expert panel prior to the selection of guidelines
RI
were rated very low regarding their applicability. This result was explained by the perception
SC
from those local providers who rated these CGs, who considered that the health care
provision where these CGs were developed was very different from the Spanish context.
U
Previous studies have reported improvement of anxiety symptoms when physicians
AN
incorporated evidence-based recommendations into their practice (14,15), invite to be
optimistic about the potential impact of the CG, although in other areas of mental health care,
M
such as schizophrenia, the combination of several guideline dissemination and
D
use (36).
Although the process of developing and implementing the CG is time-consuming, the use of
EC
adaptation methods releases an important part of this effort, although some experiences
reported that adaptation did not meet expectations for reducing time or resource
RR
commitments, e.g. in the case of cancer care (37). Nonetheless, CG adaptation methods are
being used increasingly in the mental health field (23) and for physical problems such as lung
CO
cancer (17) or back pain (18). Through these methods, high-quality CGs are being
On the other hand, the gap existing between the production of evidence and its translation
U
multifaceted process and adaptation has been found to be a key element in the knowledge-
translation continuum (37). Additionally, in our case, the involvement of leaders, experts and
end users turned out in an implementation action itself, as currently recommended. Current
12
implementation theories, models, and frameworks should be considered when trying to
Adaptation methods are not definitive; further, they may require additional resources if no
some “de novo” development might be needed for a given area (38). Expert teams should
PT
give support along the whole process to guarantee that rigour in methods is preserved. But,
despite these limitations, adaptation methods offer a way of using resources more efficiently
RI
when developing CGs, thereby avoiding unnecessary replication (16).
SC
It has been shown how the implementation of guidelines and appropriate training for health
care providers facilitate the management of anxiety disorders by GPs (39,40). Thus, adaptive
U
methods allow easily available evidence-based resources to provide GPs with
AN
recommendations on the most appropriate treatment of GAD in each case, including models
experimental study has been defined to assess the final results of this implementation
health services research and as a critical element to translate knowledge into practise (35).
The GDG set out this issue as a strategic component of the CG development to achieve
RR
issue concerning the lack of clarity in identifying the impact of users input when participating
N
in guidelines development (41). These initiatives are in line with the literature on guidelines
U
13
Acknowledgements
Guidelines for the Treatment of Generalised Anxiety Disorder: Francisco Alcaine Soria,
PT
María José Ariza Conejero, Matilde Blanco Venzalá, Pablo Cano Domínguez, Francisco
Javier Carrascoso López, María Paz Conde Gil de Montes, Carlos Cuevas Yust, María del
RI
Carmen Díaz González, Alfonso Fernández Gálvez, Carlos Fernández Oropesa, Ana Maria
SC
Fernández Pina, Ana Fernández Vargas, Joana Fornés Vives, Bienvenida Gala Fernández,
Luis Gálvez Alcaraz, Pablo García Cubillana, Francisco Javier González Mesa, María José
U
Graván Morales, Antonio Gutiérrez Iglesia, Maria Herrera Usagre, Evelyn Huizing, Juan
AN
Francisco Jiménez Estévez, Mercedes Márquez Castilla, Fermín Mayoral Cleríes, Cristina
Moreno Corona, Berta Moreno Küstner, Francisca Muñoz Cobos, Casta Quemada
M
González, Francisco Rodríguez Pulido, Javier Romero Cuesta, Modesto Ángel Ruiz Moreno,
D
José Manuel Sánchez López, Francisca Sánchez Sánchez, Jesús Sepúlveda Muñoz, Juan
TE
Financial Support: This research received no specific grant from any funding agency,
Ethical Standards:
CO
The authors assert that all procedures contributing to this work comply with the ethical
14
References
PT
regional distribution of anxiety disorders: implications for the Global Burden of
Disease Study, 2010. Int J Methods Psychiatr Res [Internet]. 2014 Dec [cited
RI
2019 Dec 4];23(4):422–38. Available from:
SC
http://www.ncbi.nlm.nih.gov/pubmed/25048296
U
AN
category. Dialogues Clin Neurosci. 2017;19(2):107–16.
mood disorders in the United States. Int J Methods Psychiatr Res [Internet].
D
http://www.ncbi.nlm.nih.gov/pubmed/22865617
EC
illness comorbidity and treatment implications. Curr Opin Psychiatry. 2019 Sep
RR
1;32(5):429–34.
http://www.ncbi.nlm.nih.gov/pubmed/27431392
Results from the second Singapore Mental Health Study. J Anxiety Disord
15
[Internet]. 2019 Aug [cited 2019 Dec 4];66:102106. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/31252250
PT
12;18(1):361.
RI
8. Fernández A, Haro JM, Codony M, Vilagut G, Martínez-Alonso M, Autonell J,
SC
et al. Treatment adequacy of anxiety and depressive disorders: primary versus
specialised care in Spain. J Affect Disord [Internet]. 2006 Nov [cited 2019 Dec
U
4];96(1–2):9–20. Available from:
9.
http://www.ncbi.nlm.nih.gov/pubmed/16793140
AN
Guidelines I of M (US) C on S for DTCP, Graham R, Mancher M, Wolman DM,
M
Greenfield S, Steinberg E. Clinical Practice Guidelines We Can Trust. Clinical
D
10. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et
http://www.ncbi.nlm.nih.gov/pubmed/21396135
N
12. Tricco AC, Ashoor HM, Cardoso R, MacDonald H, Cogo E, Kastner M, et al.
U
making: A scoping review. Implement Sci [Internet]. 2016 Apr 21 [cited 2020
16
http://www.ncbi.nlm.nih.gov/pubmed/27097827
Central Ltd.; 2016 [cited 2020 Mar 13]. p. 72. Available from:
PT
http://www.ncbi.nlm.nih.gov/pubmed/27189233
RI
14. Hepner KA, Rowe M, Rost K, Hickey SC, Sherbourne CD, Ford DE, et al. The
SC
effect of adherence to practice guidelines on depression outcomes. Ann Intern
U
15. van Dijk MK, Oosterbaan DB, Verbraak MJPM, Hoogendoorn AW, Penninx
AN
BWJH, van Balkom AJLM. Effectiveness of the implementation of guidelines
for anxiety disorders in specialized mental health care. Acta Psychiatr Scand
M
[Internet]. 2015 Jul 1 [cited 2020 Mar 7];132(1):69–80. Available from:
D
http://www.ncbi.nlm.nih.gov/pubmed/25243567
TE
framework and procedure. Vol. 18, International Journal for Quality in Health
RR
17. Chakraborty SP, Jones KM, Mazza D. Adapting lung cancer symptom
CO
reflections on the utility of the ADAPTE framework. J Eval Clin Pract [Internet].
N
http://www.ncbi.nlm.nih.gov/pubmed/24237620
18. Harstall C, Taenzer P, Zuck N, Angus DK, Moga C, Scott NA. Adapting low
17
Eval Clin Pract [Internet]. 2013 Oct [cited 2019 Dec 4];19(5):773–81. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/22845891
19. Rashid A, Thomas V, Shaw T, Leng G. Patient and Public Involvement in the
PT
20. Légaré F, Boivin A, van der Weijden T, Pakenham C, Burgers J, Légaré J, et
RI
al. Patient and public involvement in clinical practice guidelines: a knowledge
SC
synthesis of existing programs. Med Decis Making [Internet]. [cited 2019 Dec
U
http://www.ncbi.nlm.nih.gov/pubmed/21959267
21.
AN
Newman D, O’Reilly P, Lee SH, Kennedy C. Mental health service users’
22. Guideline Adaptation: A Resource Toolkit [Internet]. 2010 [cited 2019 May 3].
TE
23. Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ,
EC
24. Taylor SJ, Bogdan R, DeVault ML, Preceded by: Taylor SJ. Introduction to
N
25. Frances A, Pincus H, First M, et al. DSM-IV Diagnostic and Statistical Manual
18
26. Nogueras E V, Hurtado MM, Flordelís E, García-Herrera JM, Morales-Asencio
JM. Use of the ADAPTE Method to Develop a Guideline for the Improvement of
Depression Care in Primary Care. Psychiatr Serv [Internet]. 2017 Aug 1 [cited
http://psychiatryonline.org/doi/10.1176/appi.ps.201700163
PT
27. García-Herrera Pérez Bryan JM, Nogueras Morillas EV, Muñoz Cobos F MAJ.
RI
Guía de Práctica Clínica para el Tratamiento de la Depresión en Atención
SC
Primaria [Internet]. (Clinical Guideline for the Treatment of Depression in
U
editor. Málaga: Distrito Sanitario Málaga-UGC Salud Mental Hospital Regional
AN
Universitario de Málaga; 2011 [cited 2019 May 3]. Available from:
http://www.juntadeandalucia.es/servicioandaluzdesalud/distritomalaga/docs/sal
M
ud_mental/Guia-depresion-rapida.pdf
D
28. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al.
TE
health care. Prev Med (Baltim) [Internet]. 2010 Nov [cited 2019 May
EC
https://linkinghub.elsevier.com/retrieve/pii/S0091743510003087
31. Castillejo MM, Barrientos AM. El sistema GRADE para la toma de decisiones
19
guidelines and recommendations). Atención Primaria. 2007 Sep 1;39(9):457–
60.
PT
33. Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The
RI
GuideLine Implementability Appraisal (GLIA): development of an instrument to
SC
identify obstacles to guideline implementation. BMC Med Inform Decis Mak
U
http://www.ncbi.nlm.nih.gov/pubmed/16048653
34.
AN
Forsner T, Hansson J, Brommels M, Wistedt AA, Forsell Y. Implementing
http://doi.wiley.com/10.1002/14651858.CD009780.pub3%5Cnhttp://www.ncbi.n
lm.nih.gov/pubmed/27977851
37. Harrison MB, Graham ID, van den Hoek J, Dogherty EJ, Carley ME, Angus V.
20
Guideline adaptation and implementation planning: a prospective observational
study. Implement Sci [Internet]. 2013 May 8 [cited 2019 Dec 4];8:49. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/23656884
PT
development and improve utilisation. BMJ Qual Saf. 2011;20(3):228–36.
RI
39. Piek E, van der Meer K, Nolen WA. Guideline recommendations for long-term
SC
treatment of depression with antidepressants in primary care--a critical review.
Eur J Gen Pract [Internet]. 2010 Jun [cited 2019 Dec 4];16(2):106–12.
U
Available from: http://www.ncbi.nlm.nih.gov/pubmed/20297924
40.
AN
Sikorski C, Luppa M, König HH, Van Den Bussche H, Riedel-Heller SG. Does
41. van der Ham AJ, Shields LS, van der Horst R, Broerse JEW, van Tulder MW.
TE
guidelines: lessons from the Netherlands. Adm Policy Ment Health [Internet].
EC
http://www.ncbi.nlm.nih.gov/pubmed/24158565
42. Armstrong MJ, Rueda JD, Gronseth GS, Mullins CD. Framework for enhancing
CO
21
TABLES:
Tasks Stakeholders
PT
Preparation Preparation of operational A Guideline Development Group
framework for ADAPTE strategy (GDG) comprised of three
RI
(setting up equipment, selection psychiatrists, a clinical
of the CG themes, evaluation of psychologist, and an academic
SC
adaptability, identification and from the University with
planning of resources) expertise on evidence-based
health care, guideline
U
development and
AN
implementation.
Adaptation Definition of queries about For the definition of clinical
health topics (scope, purpose scenarios, two panels were
M
and uncertainty clinical constituted. One of them,
scenarios) constituted by 66 PCPs,
D
recommendations
U
22
composed of 9 psychiatrists, 10
psychologists, 8 PCPs, 8 nurses
specialised in mental health or
primary care, and one
PT
Additionally, internal barriers for
its implementation were
evaluated independently by two
RI
external practitioners (a PCP
with special interest in mental
SC
health and a psychiatrist).
Planning updates GDG
U
Final issue of CG GDG
AN
M
Table 2: AGREE scores of the evaluated Clinical Guidelines (CG)
D
CG
CG3(NICE CG
4(NICE, CG CG
CG1(Bal CG Common 6(Canadian
TE
Scope and purpose 94% 36% 94% 97% 86% 80% 13%
Stakeholder
43% 4% 75% 93% 58% 39% 8%
involvement
RR
Rigour of
58% 19% 90% 94% 88% 65% 9%
development
Clarity and
68% 33% 89% 89% 87% 72% 54%
CO
presentation
Applicability 11% 11% 80% 83% 52% 0% 0%
Editorial
25% 12% 91% 91% 79% 20% 33%
N
independence
U
23
Downloaded from https://academic.oup.com/intqhc/advance-article-abstract/doi/10.1093/intqhc/mzaa053/5840523 by Beurlingbiblioteket user on 23 May 2020
PT
RI
SC
U
AN
M
Table 3: Adapted and removed recommendations
D
-Psychoeducational groups for people with GAD should: to severe acquired cognitive
Be based on CBT principles, have an interactive design impairment, consider consulting
and encourage observational learning with a relevant specialist.
Include presentations and self-help manuals
CO
hours.
-CBT for people with GAD should:
U
24
trials of applied relaxation for GAD
Be delivered by trained and competent practitioners
Usually consist of 12–15 weekly sessions (fewer if the
person recovers sooner; more if clinically required), each
lasting 1 hour.
-If a person with GAD chooses drug treatment, offer a selective
PT
When treating people with
Informed consent should be obtained and documented. Monitor complex and treatment-
the person carefully for adverse reactions. refractory GAD, inform
-For people aged under 30 who are offered an SSRI or SNRI: them of relevant clinical
RI
Warn them that these drugs are associated with an research in which they may
increased risk of suicidal thinking and self-harm in a wish to participate,
SC
minority of people under 30 and working within local and
See them within 1 week of first prescribing and national ethical guidelines at all
Monitor the risk of suicidal thinking and self-harm weekly times(in United Kingdom).
U
for the first month.
-Review the effectiveness and side effects of the drug every 2–4
AN
weeks during the first 3 months of treatment and every 3 months
thereafter.
M
Table 4: Strength of recommendations (n=57)
D
In favour 26 6 11 4
EC
Against 2 0 0 0
RR
CO
Barriers
U
Lack of training on mental health, limited interest of some professionals on matters related to mental health,
not dealing with frequent problems: organisation, involvement, overdiagnosis, shortage of time and pressure
originated by the health care demand, risk of insufficient broadcasting, lack of support from scientific societies
and consultants, low involvement of Spanish clinicians with the guides and protocol, variability of clinical
practice, professionals who become saturated with information, physical co-morbidity of patients with
depression in PHC and low cooperation between primary care and mental health services.
Facilitators
25
Quality of methods, updating, lack of conflict of interests, very much pointed to primary care; institutional
backing, of a national, regional and local level, from societies; contents and recommendations may be
perceived as friendly, close, and individual; make the guide part of a computerised clinical report; to handle
more frequently depressed patients at primary care.
26